|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomassen I, van Gestel YR, Lemmens VE and
de Hingh IH: Incidence, prognosis, and treatment options for
patients with synchronous peritoneal carcinomatosis and liver
metastases from colorectal origin. Dis Colon Rectum. 56:1373–1380.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ieta K, Tanaka F, Haraguchi N, Kita Y,
Sakashita H, Mimori K, Matsumoto T, Inoue H, Kuwano H and Mori M:
Biological and genetic characteristics of tumor-initiating cells in
colon cancer. Ann Surg Oncol. 15:638–648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Li W, Nan F, Ren F, Wang H, Xu Y
and Zhang F: MicroRNA expression profile of colon cancer stem-like
cells in HT-29 adenocarcinoma cell line. Biochem Biophys Res
Commun. 404:273–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anderson EC, Hessman C, Levin TG, Monroe
MM and Wong MH: The role of colorectal cancer stem cells in
metastatic disease and therapeutic response. Cancers. 3:319–339.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang EH and Wicha MS: Colon cancer stem
cells: Implications for prevention and therapy. Trends Mol Med.
14:503–509. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang DD, Kim YJ, Lee CN, Aggarwal S,
McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, et al:
Expansion of CD133+ colon cancer cultures retaining stem
cell properties to enable cancer stem cell target discovery. Br J
Cancer. 102:1265–1275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meyer N and Penn LZ: Reflecting on 25
years with MYC. Nat Rev Cancer. 8:976–990. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Wang H, Li Z, Wu Q, Lathia JD,
McLendon RE, Hjelmeland AB and Rich JN: c-Myc is required for
maintenance of glioma cancer stem cells. PLoS One. 3:e37692008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Porro A, Haber M, Diolaiti D, Iraci N,
Henderson M, Gherardi S, Valli E, Munoz MA, Xue C, Flemming C, et
al: Direct and coordinate regulation of ATP-binding cassette
transporter genes by Myc factors generates specific transcription
signatures that significantly affect the chemoresistance phenotype
of cancer cells. J Biol Chem. 285:19532–19543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Porro A, Iraci N, Soverini S, Diolaiti D,
Gherardi S, Terragna C, Durante S, Valli E, Kalebic T, Bernardoni
R, et al: c-MYC oncoprotein dictates transcriptional profiles of
ATP-binding cassette transporter genes in chronic myelogenous
leukemia CD34+ hematopoietic progenitor cells. Mol
Cancer Res. 9:1054–1066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie ZY, Lv K, Xiong Y and Guo WH:
ABCG2-meditated multidrug resistance and tumor-initiating capacity
of side population cells from colon cancer. Oncol Res Treat.
37:666–668, 670–672. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Y, Hou J, Li G, Song Z, Li X, Yang C,
Liu W, Hu Y and Xu Y: ABCG2 regulates the pattern of self-renewing
divisions in cisplatin-resistant non-small cell lung cancer cell
lines. Oncol Rep. 32:2168–2174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie N, Mou L, Yuan J, Liu W, Deng T, Li Z,
Jing Y and Hu Z: Modulating drug resistance by targeting
BCRP/ABCG2 using retrovirus-mediated RNA interference. PLoS
One. 9:e1034632014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kugimiya N, Nishimoto A, Hosoyama T, Ueno
K, Enoki T, Li TS and Hamano K: The c-MYC-ABCB5 axis has a pivotal
role in 5-fluorouracil resistance in human colon cancer cells. J
Cell Mol Med. 19:1569–1581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amini S, Fathi F, Mobalegi J,
Sofimajidpour H and Ghadimi T: The expressions of stem cell
markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3,
Dppa4, and Esrrb in bladder, colon, and prostate cancer, and
certain cancer cell lines. Anat Cell Biol. 47:1–11. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao L, Bombard J, Cintron K, Sheedy J,
Weetall ML and Davis TW: BMI1 as a novel target for drug discovery
in cancer. J Cell Biochem. 112:2729–2741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
James MI, Iwuji C, Irving G, Karmokar A,
Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR,
et al: Curcumin inhibits cancer stem cell phenotypes in ex vivo
models of colorectal liver metastases, and is clinically safe and
tolerable in combination with FOLFOX chemotherapy. Cancer Lett.
364:135–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Todaro M, Alea MP, Di Stefano AB,
Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G,
Medema JP, et al: Colon cancer stem cells dictate tumor growth and
resist cell death by production of interleukin-4. Cell Stem Cell.
1:389–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kreso A, van Galen P, Pedley NM,
Lima-Fernandes E, Frelin C, Davis T, Cao L, Baiazitov R, Du W,
Sydorenko N, et al: Self-renewal as a therapeutic target in human
colorectal cancer. Nat Med. 20:29–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeuner A, Todaro M, Stassi G and De Maria
R: Colorectal cancer stem cells: From the crypt to the clinic. Cell
Stem Cell. 15:692–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
